The COVID-19 related stocks we`ve found have gained 15% on average during the past month
SmallCapPower | March 19, 2020: Coronavirus (COVID-19) outbreak fears have slammed most global stock prices in an unprecedented selloff over a one-month time period. The four COVID-19 related stocks we have identified today, though, have performed relatively well, gaining 15% on average over the past 30 days.
The Clorox Company (NYSE:CLX) – US$190.95
The multinational manufacturer and marketer of consumer and professional products had fiscal 2019 net sales of US$6.2 billion. When consumers think of Clorox, bleach probably comes to mind first, but the Company also produces disinfecting wipes in addition to well-known brands such as Glad garbage bags and Pine-Sol liquid cleaner. Regardless of the recent hoarding, COVID-19 will likely result in a generation shift in how consumers view household disinfection products. Its stock has a current dividend yield north of 2%.
Gilead Sciences, Inc. (NASDAQ:GILD) – US$79.42
Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. Gilead’s experimental drug remdesivir might be the best option for treating coronavirus (COVID-19). As well, the Company’s HIV drugs generate billions of dollars in sales. Gilead also has its CAR-T cell therapies for treating cancer and its treatment of rheumatoid arthritis, filgotinib, could receive FDA approval later this year. Gilead stock is currently yielding nearly 4%.
Teladoc Health (NYSE:TDOC) – $136.93
Teladoc is a provider of virtual healthcare services. The Company announced that patient visits during the week of March 9, 2020 surged 50% over the prior week to approximately 100,000 virtual medical visits. In a worst-case coronavirus scenario, the traditional health care system will likely not have the capacity to effectively handle the patient volumes, which would benefit Teladoc Health.
Campbell Soup Company (NYSE:CPB) – $50.48
Who doesn’t like soup? Consumers have been stocking up on cans, which have a long shelf life, preparing for a potential extended period of self isolation due to the rapidly-spreading coronavirus outbreak. Campbell Soup`s most recently-reported quarter (Q2 2020) saw the Company surpass revenue and earnings estimates and this was before the current COVID-19 craziness. As well, Campbell`s debt reduction efforts allowed it to raise its 2020 adjusted EPS outlook to between $2.55 to $2.60. CPB stock has a current dividend yield of 2.6%.
Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.
To read our full disclosure, please click on the button below: